Terms: = Prostate cancer AND MEN1, ENSG00000133895, 4221
20 results:
1. Menin-MLL1 Interaction Small Molecule Inhibitors: A Potential Therapeutic Strategy for Leukemia and cancers.
Shi Q; Xu M; Kang Z; Zhang M; Luo Y
Molecules; 2023 Mar; 28(7):. PubMed ID: 37049787
[TBL] [Abstract] [Full Text] [Related]
2. prostate Health Index Density Outperforms prostate-specific Antigen Density in the Diagnosis of Clinically Significant prostate cancer in Equivocal Magnetic Resonance Imaging of the prostate: A Multicenter Evaluation.
Chiu PK; Leow JJ; Chiang CH; Mok A; Zhang K; Hsieh PF; Zhu Y; Lam W; Tsang WC; Fan YH; Lin TP; Chan TY; Leung CH; Teoh JY; Chu PS; Zhu G; Ye DW; Wu HC; Tan TW; Tsu JH; Ng CF; Chiong E; Huang CY
J Urol; 2023 Jul; 210(1):88-98. PubMed ID: 37036248
[TBL] [Abstract] [Full Text] [Related]
3. Menin Enhances Androgen Receptor-Independent Proliferation and Migration of prostate cancer Cells.
Kim T; Jeong K; Kim E; Yoon K; Choi J; Park JH; Kim JH; Kim HS; Youn HD; Cho EJ
Mol Cells; 2022 Apr; 45(4):202-215. PubMed ID: 35014621
[TBL] [Abstract] [Full Text] [Related]
4. Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity.
Cherif C; Nguyen DT; Paris C; Le TK; Sefiane T; Carbuccia N; Finetti P; Chaffanet M; Kaoutari AE; Vernerey J; Fazli L; Gleave M; Manai M; Barthélémy P; Birnbaum D; Bertucci F; Taïeb D; Rocchi P
Oncogene; 2022 Jan; 41(1):125-137. PubMed ID: 34711954
[TBL] [Abstract] [Full Text] [Related]
5. men1 silencing aggravates tumorigenic potential of AR-independent prostate cancer cells through nuclear translocation and activation of JunD and β-catenin.
Luo Y; Vlaeminck-Guillem V; Baron S; Dallel S; Zhang CX; Le Romancer M
J Exp Clin Cancer Res; 2021 Aug; 40(1):270. PubMed ID: 34446068
[TBL] [Abstract] [Full Text] [Related]
6. men1 disruption in Nkx3.1-deficient mice results in AR
Teinturier R; Luo Y; Decaussin-Petrucci M; Vlaeminck-Guillem V; Vacherot F; Firlej V; Bonnavion R; Abou Ziki R; Gherardi S; Goddard I; Gadot N; Bertolino P; Le Romancer M; Zhang CX
Oncogene; 2021 Feb; 40(6):1118-1127. PubMed ID: 33323967
[TBL] [Abstract] [Full Text] [Related]
7. Risk of second primary malignancies among patients with carcinoid of the lung.
Buikhuisen WA; Steinbusch LC; Kodach LL; Tesselaar MET; Damhuis RAM
Lung Cancer; 2021 Jan; 151():5-7. PubMed ID: 33278670
[TBL] [Abstract] [Full Text] [Related]
8. An organoid-based drug screening identified a menin-MLL inhibitor for endometrial cancer through regulating the HIF pathway.
Chen J; Zhao L; Peng H; Dai S; Quan Y; Wang M; Wang J; Bi Z; Zheng Y; Zhou S; Liu Y; Chen C; Na F
Cancer Gene Ther; 2021 Feb; 28(1-2):112-125. PubMed ID: 32632269
[TBL] [Abstract] [Full Text] [Related]
9. CHEK2 Mutation in Patient with Multiple Endocrine Glands Tumors. Case Report.
Szeliga A; Pralat A; Witczak W; Podfigurna A; Wojtyla C; Kostrzak A; Meczekalski B
Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32570972
[TBL] [Abstract] [Full Text] [Related]
10. Co-occurrence of multiple endocrine neoplasia type 4 and spinal neurofibromatosis: a case report.
Brock P; Bustamante Alvarez J; Mortazavi A; Roychowdhury S; Phay J; Khawaja RA; Shah MH; Konda B
Fam Cancer; 2020 Apr; 19(2):189-192. PubMed ID: 32052251
[TBL] [Abstract] [Full Text] [Related]
11. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
12. prostate cancer Incidence and Mortality in Relationship to Family History of prostate cancer; Findings From The PLCO Trial.
Abdel-Rahman O
Clin Genitourin Cancer; 2019 Aug; 17(4):e837-e844. PubMed ID: 31213414
[TBL] [Abstract] [Full Text] [Related]
13. PRDM16 is associated with evasion of apoptosis by prostatic cancer cells according to RNA interference screening.
Zhu S; Xu Y; Song M; Chen G; Wang H; Zhao Y; Wang Z; Li F
Mol Med Rep; 2016 Oct; 14(4):3357-61. PubMed ID: 27511603
[TBL] [Abstract] [Full Text] [Related]
14. Multiple endocrine neoplasia type 1 associated with a new germline men1 mutation in a family with atypical tumor phenotype.
Perakakis N; Flohr F; Kayser G; Thomusch O; Parsons L; Billmann F; von Dobschuetz E; Rondot S; Seufert J; Laubner K
Hormones (Athens); 2016; 15(1):113-7. PubMed ID: 26732163
[TBL] [Abstract] [Full Text] [Related]
15. Mutation detection in formalin-fixed prostate cancer biopsies taken at the time of diagnosis using next-generation DNA sequencing.
Manson-Bahr D; Ball R; Gundem G; Sethia K; Mills R; Rochester M; Goody V; Anderson E; O'Meara S; Flather M; Keeling M; Yazbek-Hanna M; Hurst R; Curley H; Clark J; Brewer DS; McDermott U; Cooper C
J Clin Pathol; 2015 Mar; 68(3):212-7. PubMed ID: 25586381
[TBL] [Abstract] [Full Text] [Related]
16. Single-cell genetic analysis reveals insights into clonal development of prostate cancers and indicates loss of PTEN as a marker of poor prognosis.
Heselmeyer-Haddad KM; Berroa Garcia LY; Bradley A; Hernandez L; Hu Y; Habermann JK; Dumke C; Thorns C; Perner S; Pestova E; Burke C; Chowdhury SA; Schwartz R; Schäffer AA; Paris PL; Ried T
Am J Pathol; 2014 Oct; 184(10):2671-86. PubMed ID: 25131421
[TBL] [Abstract] [Full Text] [Related]
17. Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids.
Fernandez-Cuesta L; Peifer M; Lu X; Sun R; Ozretić L; Seidal D; Zander T; Leenders F; George J; Müller C; Dahmen I; Pinther B; Bosco G; Konrad K; Altmüller J; Nürnberg P; Achter V; Lang U; Schneider PM; Bogus M; Soltermann A; Brustugun OT; Helland Å; Solberg S; Lund-Iversen M; Ansén S; Stoelben E; Wright GM; Russell P; Wainer Z; Solomon B; Field JK; Hyde R; Davies MP; Heukamp LC; Petersen I; Perner S; Lovly C; Cappuzzo F; Travis WD; Wolf J; Vingron M; Brambilla E; Haas SA; Buettner R; Thomas RK
Nat Commun; 2014 Mar; 5():3518. PubMed ID: 24670920
[TBL] [Abstract] [Full Text] [Related]
18. The association of telomere length and genetic variation in telomere biology genes.
Mirabello L; Yu K; Kraft P; De Vivo I; Hunter DJ; Prescott J; Wong JY; Chatterjee N; Hayes RB; Savage SA
Hum Mutat; 2010 Sep; 31(9):1050-8. PubMed ID: 20597107
[TBL] [Abstract] [Full Text] [Related]
19. An oncogenic role for the multiple endocrine neoplasia type 1 gene in prostate cancer.
Paris PL; Sridharan S; Hittelman AB; Kobayashi Y; Perner S; Huang G; Simko J; Carroll P; Rubin MA; Collins C
Prostate Cancer Prostatic Dis; 2009; 12(2):184-91. PubMed ID: 18779856
[TBL] [Abstract] [Full Text] [Related]
20. Global gene expression in neuroendocrine tumors from patients with the men1 syndrome.
Dilley WG; Kalyanaraman S; Verma S; Cobb JP; Laramie JM; Lairmore TC
Mol Cancer; 2005 Feb; 4(1):9. PubMed ID: 15691381
[TBL] [Abstract] [Full Text] [Related]
